Sanofi to use Biomunex’s BiXAb platform to generate antibody therapeutics

Image: Sanofi will use Biomunex’s BiXAb platform to generate and optimize antibody therapeutics. Photo: courtesy of Baitong333 / FreeDigitalPhotos.net.